Petra Seibold Selected Research

Petra Seibold Research Topics

Disease

32	Breast Neoplasms (Breast Cancer) 05/2022 - 05/2011
18	Neoplasms (Cancer) 11/2022 - 01/2013
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 12/2016
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 06/2016
3	Genetic Risk Score 11/2022 - 05/2015
3	Lung Neoplasms (Lung Cancer) 11/2022 - 04/2018
3	Fibrosis (Cirrhosis) 01/2019 - 12/2012
2	Neoplasm Metastasis (Metastasis) 02/2016 - 01/2013
2	Hypertension (High Blood Pressure) 01/2016 - 09/2014
2	Carcinoma (Carcinomatosis) 01/2016 - 04/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Hematuria 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Erythema 01/2020
1	Telangiectasis (Telangiectasia) 01/2019
1	Radiation Fibrosis Syndrome (Radiation Fibrosis) 03/2016
1	Second Primary Neoplasms (Neoplasms, Second) 02/2016
1	Familial Breast Cancer 02/2015
1	Depressive Disorder (Melancholia) 01/2015
1	Pain (Aches) 01/2015
1	Fatigue 01/2015
1	Arthritis (Polyarthritis) 01/2015
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2015
1	Migraine Disorders (Migraine) 01/2015
1	Inflammation (Inflammations) 06/2014
1	Ovarian Neoplasms (Ovarian Cancer) 04/2014
1	Endometrioid Carcinoma 04/2014
1	Hypersensitivity (Allergy) 12/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2013
1	Pathologic Complete Response 02/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2013
1	Carcinogenesis 09/2011

Drug/Important Bio-Agent (IBA)

13	Estrogen ReceptorsIBA 12/2017 - 05/2011
7	Hormones (Hormone)IBA 05/2016 - 05/2011
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 06/2016
2	Genetic Markers (Genetic Marker)IBA 01/2022 - 05/2015
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
2	betaglycan (TGFBR3)IBA 12/2020 - 04/2014
2	Fluorouracil (Carac)FDA LinkGeneric 07/2018 - 06/2016
2	mahuang-tangIBA 05/2016 - 04/2013
2	Biological ProductsIBA 11/2015 - 02/2013
2	3' Untranslated Regions (3' UTR)IBA 02/2015 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 02/2015 - 09/2013
2	Progesterone Receptors (Progesterone Receptor)IBA 09/2013 - 01/2013
2	Estrogens (Estrogen)FDA Link 04/2013 - 01/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013 - 09/2011
1	ORALIT (ORS)IBA 11/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	AngiotensinogenIBA 01/2022
1	Interleukin-7 (Interleukin 7)IBA 12/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	CarbonIBA 07/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2018
1	Diacylglycerol KinaseIBA 03/2016
1	Transcription Factors (Transcription Factor)IBA 03/2016
1	AnthracyclinesIBA 12/2015
1	Transforming Growth Factor-beta Type II ReceptorIBA 02/2015
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2015
1	ChromatinIBA 01/2015
1	Aromatase InhibitorsIBA 01/2015
1	Analgesics (Analgesic Drugs)IBA 01/2015
1	Trastuzumab (Herceptin)FDA Link 09/2014
1	LignansIBA 08/2014
1	2,3-bis(3'-hydroxybenzyl)butyrolactone (enterolactone)IBA 08/2014
1	hydroxide ionIBA 06/2014
1	25-hydroxyvitamin DIBA 06/2014
1	Interleukin-10 (Interleukin 10)IBA 04/2014
1	Oral ContraceptivesIBA 04/2014
1	Transforming Growth Factor-beta Type I ReceptorIBA 04/2014
1	Interleukin-6 (Interleukin 6)IBA 04/2014
1	Interleukin-8 (Interleukin 8)IBA 04/2014
1	Interleukin-15 (Interleukin 15)IBA 04/2014
1	Galectin 1 (LGALS1)IBA 04/2014
1	Transforming Growth Factor beta3 (TGF beta 3)IBA 04/2014
1	MicroRNAs (MicroRNA)IBA 01/2014
1	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2013
1	Deoxyribonucleases (DNase)FDA Link 12/2013
1	Phenobarbital (Luminal)FDA Link 09/2013
1	Growth Factor ReceptorsIBA 09/2013
1	Estrone FDA Link 04/2013
1	Codon (Codons)IBA 02/2013
1	valylvaline (Val-Val)IBA 02/2013
1	LipidsIBA 01/2013
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2013
1	DNA Polymerase gammaIBA 01/2013
1	Messenger RNA (mRNA)IBA 01/2013
1	MetallothioneinIBA 09/2011
1	NADPH Oxidases (NAD(P)H oxidase)IBA 09/2011
1	ThioredoxinsIBA 09/2011
1	Coffee FDA Link 05/2011

Therapy/Procedure

18	Radiotherapy 11/2022 - 01/2013
7	Therapeutics 05/2016 - 12/2012
6	Drug Therapy (Chemotherapy) 01/2022 - 06/2014
4	Adjuvant Chemotherapy 01/2022 - 02/2015
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 04/2013 - 09/2011
1	Segmental Mastectomy (Lumpectomy) 01/2020
1	Adjuvant Radiotherapy 04/2018
1	Neoadjuvant Therapy 02/2013